<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: For Now, Mylan Remains Sole Generic Norvasc Seller</title>
	<atom:link href="http://www.patentbaristas.com/archives/2007/04/23/for-now-mylan-remains-sole-generic-norvasc-seller/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.patentbaristas.com/archives/2007/04/23/for-now-mylan-remains-sole-generic-norvasc-seller/</link>
	<description>Freshly Brewed Bio/Pharma Chat. Served Up Daily.</description>
	<lastBuildDate>Thu, 18 Mar 2010 11:54:35 -0400</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.2</generator>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>By: GenericIPGuy</title>
		<link>http://www.patentbaristas.com/archives/2007/04/23/for-now-mylan-remains-sole-generic-norvasc-seller/comment-page-1/#comment-6197</link>
		<dc:creator>GenericIPGuy</dc:creator>
		<pubDate>Tue, 24 Apr 2007 04:03:21 +0000</pubDate>
		<guid isPermaLink="false">http://www.patentbaristas.com/archives/2007/04/23/for-now-mylan-remains-sole-generic-norvasc-seller/#comment-6197</guid>
		<description>In a sense, it gives the exclusivty to Mylan, who possibly deserved it.

So, till the time the Court Mandate arrives, Mylan and Pfizer + Pfizer&#039;s authorsied generic will rule the market.</description>
		<content:encoded><![CDATA[<p>In a sense, it gives the exclusivty to Mylan, who possibly deserved it.</p>
<p>So, till the time the Court Mandate arrives, Mylan and Pfizer + Pfizer&#8217;s authorsied generic will rule the market.</p>
]]></content:encoded>
	</item>
</channel>
</rss>
